|
Edit
Article
Clinical trial
data management outsourcing to India
As the industry grows many players are modulating their
business portfolio to accommodate the industry’s
needs. India has of late seen those changes in the operations
of IT and ITES companies who have expanded their operations
to other business segments like bioinformatics, life
science, data management etc, says Dr Umakanta Sahoo
in the first part of the article
|
Decoding
the US Pharmacoepia
Sold in 131 countries the USP-NF acts as a reference
point to many regulators in countries that lack an official
Pharmacopoeia and it will continue to do so as pharmaceutical
manufacturing becomes increasingly globalised
|
|
‘VAT
is only going to bring greater transparency’
The much-awaited, discussed, debated and deferred several
times, Value Added Tax (VAT), supposedly one of the
biggest Indian tax reform since independence, got introduced
on April 1, 2005 in 20 Indian states. The remaining
states are yet to decide whether or not to adopt it
but it appears they may introduce it soon. Hitesh Sharma,
Partner, Ernst & Young, talks to Divya Nair about
the present status of the VAT regime, the differences
in opinion surrounding its implementation across the
country, and impact on the pharmaceutical industry in
India.
|
